Adapted from the presentation ‘COPD – Where are we now?’, which took place at the Frontiers in Respiratory Medicine meeting, October 21st, 2011. MIMS Ireland Copyright®
Update on COPD
January 1, 2012 By Leave a Comment
Prevalence Moderate and Severe COPD affects one in 10 people The prevalence of COPD is increasing in Ireland, and COPD is expected to be the third cause of death by 2020. BOLD, a worldwide study including close to 10,000 participants, aimed to measure the prevalence of COPD, its risk factors and their variation across countries [...]
Preventing and treating COPD
March 31, 2011 By Leave a Comment
Dr Ross Morgan outlines the different grading systems in chronic obstructive pulmonary disease and the various treatment methods tailored for different patient types. Chronic obstructive pulmonary disease (COPD) is a progressive condition that is almost entirely preventable. It is increasingly recognised that there are significant extra-pulmonary effects that contribute to morbidity in the COPD patient. [...]
Prescribing the right balance of combination therapies
January 13, 2011 By Leave a Comment
Dr Reggie Spelman looks at the latest studies and international best-practice guidelines for prescribing combination therapies Combination therapies comprise an inhaled corticosteroid (ICS) and a long-acting β agonist (LABA), providing a dual anti-inflammatory and bronchodilator action. According to the British Thoracic Society (BTS) asthma guidelines, LABAs are the first choice of add-on therapy to inhaled [...]
World COPD Day urges disease awareness
November 11, 2010 By Leave a Comment
This year’s World COPD Day focuses on increasing awareness of spirometry as a simple and painless way to determine lung health World COPD Day is a global effort to boost people’s understanding of COPD and advocate for better care for patients. The aim of the awareness day this year, which falls on November 17, is [...]
Reduction in disease progression
November 4, 2010 By Leave a Comment
Clinical update on Chronic obstructive pulmonary disease By Gary Culliton There is growing awareness of the benefits of newer drugs for the treatment of chronic obstructive pulmonary disease (COPD). “The principal thing is to stop smoking, although these drugs do seem to hold out promise of slowing down disease progression, even in earlier stages of [...]
Outreach programmes cut down hospital stays hugely
November 4, 2010 By Leave a Comment
Studies have shown that patients dislike and fear stays in hospital. Outreach COPD programmes, which began internationally ten years ago, have demonstrated great benefits for patients, families and hospitals. An outreach programme was initially set up in St James’s Hospital by Prof Luke Clancy and Dr Barry O’Connell in 2002. The programme — run by [...]
‘Faster decline’ in women COPD patients’ lung function
November 4, 2010 By Leave a Comment
Female smokers may be more susceptible to COPD, Prof Luke Clancy of the Research Institute for a Tobacco-Free Society told the ‘Beyond the Guidelines’ conference in Dublin on October 2. Prof Clancy cited a 2007 paper published by Sin et al in the journal Proceedings of the American Thoracic Society. Evidence that female smokers have [...]
Phenotypes are the future of COPD
August 24, 2010 By Leave a Comment
Mary Anne Kenny reports from the COPD7 International Conference in Birmingham, where experts stressed the need for tailored approaches to COPD Respiratory experts from all over the world gathered in Birmingham, UK, recently for the COPD7 International Conference on chronic obstructive pulmonary disease (COPD). The international, multi-disciplinary conference, which ran from 30 June to 2 [...]
Early treatment linked to better COPD outcomes
June 15, 2010 By Leave a Comment
Among patients hospitalised for acute exacerbations of chronic obstructive pulmonary disease (COPD), those who received antibiotics in the first two hospital days had improved outcomes, according to a new American study. In the study, doctors examined the association between the use of antibiotics and outcomes among patients hospitalised for acute exacerbations of COPD at 413 [...]
Loading ...
